Want to see CON full AI Analyst Report?
CON Stock Chart & Stats
$31.61
$0.08(0.25%)
At close: 4:00 PM EDT
$31.61
$0.08(0.25%)
Day’s Range― - ―
52-Week Range$18.55 - $35.15
Previous CloseN/A
Volume1.25M
Average Volume (3M)1.01M
Market Cap
$4.35B
Enterprise Value$5.82K
Total Cash (Recent Filing)$158.04M
Total Debt (Recent Filing)$2.14B
Price to Earnings (P/E)21.3
Beta0.56
Next Earnings
Oct 29, 2026EPS Estimate
0.44Next Dividend Ex-DateN/A
Dividend Yield0.76%
Share Statistics
EPS (TTM)1.55
Shares Outstanding127,517,740
10 Day Avg. Volume889,754
30 Day Avg. Volume1,008,042
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$39.13Price Target Upside23.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.61
Revenue Forecast (FY)$2.34B
Bulls Say, Bears Say
Bulls Say
Top-line MomentumSustained double-digit and TTM revenue growth reflects durable demand for occupational and onsite health services, expanding visit volumes and revenue-per-visit. This persistent top-line expansion supports scale advantages, reinvestment capacity, and gives management runway to reduce leverage over the next 2–6 months.
Margin Expansion & Cost EfficiencyMeaningful margin improvement driven by lower cost of services, staffing efficiencies and realized synergies from acquisitions indicates structural operating leverage. Higher and more efficient EBITDA conversion increases sustainable cash flow and resilience to moderate revenue normalizations in the medium term.
Planned Leadership SuccessionA formal, board-approved internal succession preserves strategic continuity and reduces executive-transition risk. Promoting the CFO/President to CEO signals governance planning and operational familiarity, supporting consistent execution of de‑leveraging, de novo rollout, and integration agendas over the coming months.
Bears Say
High Leverage & Thinner Equity CushionMaterial debt growth and a shrunken equity base leave the company more sensitive to refinancing risk and earnings shocks. Elevated leverage constrains strategic flexibility, increases interest and covenant risk, and makes successful, sustained deleveraging a critical near-term requirement for financial stability.
Slow De Novo / Acquisition Ramp TimingGrowth reliant on de novo openings and acquired assets faces timing risk: new sites and integrations take many months to reach contribution targets. Delayed ramping reduces near-term revenue and cash benefits, raising execution risk and making forecasted deleveraging and returns more contingent on integration success.
Seasonality And Visit-growth NormalizationSeasonal quarters and guidance for visit growth to revert to low-single-digits imply margin and revenue volatility across the year. Structural seasonality and expected rate normalization temper the sustainability of Q2 margin gains, reducing visibility into full-year profitability and cash flow patterns.
Concentra Group Holdings Parent, Inc. News
CON FAQ
What was Concentra Group Holdings Parent, Inc.’s price range in the past 12 months?
Concentra Group Holdings Parent, Inc. lowest stock price was $18.55 and its highest was $35.15 in the past 12 months.
What is Concentra Group Holdings Parent, Inc.’s market cap?
Concentra Group Holdings Parent, Inc.’s market cap is $4.35B.
When is Concentra Group Holdings Parent, Inc.’s upcoming earnings report date?
Concentra Group Holdings Parent, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 78 days.
How were Concentra Group Holdings Parent, Inc.’s earnings last quarter?
Concentra Group Holdings Parent, Inc. released its earnings results on Aug 06, 2026. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.422 by $0.098.
Is Concentra Group Holdings Parent, Inc. overvalued?
According to Wall Street analysts Concentra Group Holdings Parent, Inc.’s price is currently Undervalued.
Does Concentra Group Holdings Parent, Inc. pay dividends?
Concentra Group Holdings Parent, Inc. pays a Quarterly dividend of $0.063 which represents an annual dividend yield of 0.76%. See more information on Concentra Group Holdings Parent, Inc. dividends here
What is Concentra Group Holdings Parent, Inc.’s EPS estimate?
Concentra Group Holdings Parent, Inc.’s EPS estimate is 0.44.
How many shares outstanding does Concentra Group Holdings Parent, Inc. have?
Concentra Group Holdings Parent, Inc. has 127,517,740 shares outstanding.
What happened to Concentra Group Holdings Parent, Inc.’s price movement after its last earnings report?
Concentra Group Holdings Parent, Inc. reported an EPS of $0.52 in its last earnings report, beating expectations of $0.422. Following the earnings report the stock price went up 11.526%.
Which hedge fund is a major shareholder of Concentra Group Holdings Parent, Inc.?
Currently, no hedge funds are holding shares in CON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concentra Group Holdings Parent, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$39.13 (23.77% Upside)
$39.13 (23.77% Upside)
Blogger Sentiment
Bullish
CON Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 153.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $14.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.0%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.33%
12-Months-Change
Fundamentals
Return on Equity
0.76%
Trailing 12-Months
Asset Growth
5.94%
Trailing 12-Months
Company Description
Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.
CON Company Deck
CON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call delivers a broadly positive message: robust top-line growth (10% revenue increase), notable margin expansion (EBITDA +22.5% and ~240 bps improvement), strong cash generation (operating cash flow and free cash flow roughly doubled YoY), successful acquisitions (Pivot/Nova ahead of underwriting), and updated, higher 2026 guidance. Manageable lowlights include comparability benefits from prior-year one-offs, expected moderation toward long-term visit growth, seasonality affecting margins, remaining debt/leveraging goals, and limited short-term contribution from new de novos. Overall, the strengths materially outweigh the risks and caveats discussed.View all CON earnings summariesCON Stock 12 Month Forecast
Average Price Target
$39.13
▲(23.77% Upside)
Technical Analysis
Labcorp Holdings
―
Envista Holdings
―
Safe Pro Group, Inc.
―
Flowco Holdings Inc Class A
―
Beta Bionics, Inc.
―
Ownership Overview
7.85% Insiders
34.16% Mutual Funds
5.18% Other Institutional Investors
27.90% Public Companies and
Individual Investors